Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jami R Erickson

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Immunology (Baltimore, Md. : 1950)|December 3, 2013
CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of gliomaKatherine A Murphy, Jami R Erickson, Charles S Johnson, et al.
Nature|May 11, 2022
Extricating human tumour immune alterations from tissue inflammationFlorian Mair, Jami R Erickson, Marie Frutoso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2012
An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomasKatherine A Murphy, Melissa G Lechner, Flavia E Popescu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2025
Cytokine and metabolite networks shape T cell residency and functionality at the term human maternal-fetal interfaceNicholas J Maurice, Jami R Erickson, Caitlin S DeJong, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Converging cytokine and metabolite networks shape asymmetric T cell fate at the term human maternal-fetal interfaceNicholas J Maurice, Jami R Erickson, Caitlin S DeJong, et al.
Science Translational Medicine|December 6, 2019
The human tissue-resident CCR5<sup>+</sup> T cell compartment maintains protective and functional properties during inflammationAmanda S Woodward Davis, Hayley N Roozen, Matthew J Dufort, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Immunology (Baltimore, Md. : 1950)|December 3, 2013
CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of gliomaKatherine A Murphy, Jami R Erickson, Charles S Johnson, et al.
Nature|May 11, 2022
Extricating human tumour immune alterations from tissue inflammationFlorian Mair, Jami R Erickson, Marie Frutoso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2012
An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomasKatherine A Murphy, Melissa G Lechner, Flavia E Popescu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2025
Cytokine and metabolite networks shape T cell residency and functionality at the term human maternal-fetal interfaceNicholas J Maurice, Jami R Erickson, Caitlin S DeJong, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Converging cytokine and metabolite networks shape asymmetric T cell fate at the term human maternal-fetal interfaceNicholas J Maurice, Jami R Erickson, Caitlin S DeJong, et al.
Science Translational Medicine|December 6, 2019
The human tissue-resident CCR5<sup>+</sup> T cell compartment maintains protective and functional properties during inflammationAmanda S Woodward Davis, Hayley N Roozen, Matthew J Dufort, et al.
Pageof 2